Lu Guo
Impact in
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
- Hepatology 12
- Hepatocellular Carcinoma Treatment and Prognosis 12
-
- Cancer, Lipids, and Metabolism 1
- Cancer-related molecular mechanisms research 1
- Co-authors
- Ke Su (7 shared papers)Hao Zeng (7 shared papers)Ke Xu (5 shared papers)Tao Gu (5 shared papers)Zhenying Wu (4 shared papers)Yunwei Han (5 shared papers)Kun He (4 shared papers)Han Li (4 shared papers)
- Journals
- Frontiers in Immunology (2 papers)Clinical and Experimental Medicine (2 papers)Biology Direct (1 paper)Frontiers in Oncology (1 paper)Hepatology International (1 paper)
- Partner nations
- China
In The Last Decade
Lu Guo
17 papers receiving 345 citations
Peers
Comparison fields: 5 of 44
- Hepatology 189
- Drug Discovery 4
- Oncology 66
- Cancer Research 28
- Molecular Biology 57
Countries citing papers authored by Lu Guo
This map shows the geographic impact of Lu Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lu Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lu Guo more than expected).
Fields of papers citing papers by Lu Guo
This network shows the impact of papers produced by Lu Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lu Guo. The network helps show where Lu Guo may publish in the future.
Co-authors
The 25 scholars most cited alongside Lu Guo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 44 | |
| 2 | 2022 | 38 | |
| 3 | 2022 | 36 | |
| 4 | 2023 | 36 | |
| 5 | 2022 | 35 | |
| 6 | 2023 | 34 | |
| 7 | 2023 | 33 | |
| 8 | 2023 | 32 | |
| 9 | 2022 | 18 | |
| 10 | 2022 | 10 | |
| 11 | 2023 | 9 | |
| 12 | 2024 | 9 | |
| 13 | 2023 | 5 | |
| 14 | 2025 | 5 | |
| 15 | 2023 | 3 | |
| 16 | 2023 | 3 | |
| 17 | 2022 | 2 |
About Lu Guo
Lu Guo is a scholar working on Hepatology, Cancer Research, Oncology, Radiology, Nuclear Medicine and Imaging and Molecular Biology, having authored 17 papers that have together received 352 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (12 papers), Cancer Immunotherapy and Biomarkers (2 papers), Cancer, Lipids, and Metabolism (1 paper), RNA modifications and cancer (1 paper), Corneal surgery and disorders (1 paper) and Cancer-related molecular mechanisms research (1 paper). The work is most often cited by research in Hepatology (189 citations), Drug Discovery (4 citations), Oncology (66 citations), Cancer Research (28 citations) and Molecular Biology (57 citations). Lu Guo has collaborated with scholars based in China. Frequent co-authors include Ke Su, Hao Zeng, Ke Xu, Tao Gu, Zhenying Wu, Yunwei Han, Kun He, Han Li, Hao Chi and Yi Jiang. Their work appears in journals such as Frontiers in Immunology, Clinical and Experimental Medicine, Biology Direct, Frontiers in Oncology and Hepatology International.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.